EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

A Review of Sex and Gender Factors in Stimulant Treatment for ADHD: Knowledge Gaps and Future Directions

Iris L Rapoport iD, Annabeth P Groenman iD

Journal of Attention Disorders · 2025-06 · 29 (8) · 602-616

DOI: 10.1177/10870547251315601 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Attention Disorders, online erschienen am 29.01.2025. Verfasst von Iris L Rapoport und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: universiteit van amsterdam.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Stimulant medications are the primary pharmacological intervention for ADHD, yet our understanding of how sex and gender impact stimulant treatment outcomes remains limited. Clinical guidelines do not differ for female and male individuals despite possible sex and gender-related differences in effectiveness, adverse events, and pharmacokinetics. This theoretical framework identifies five key knowledge gaps relating to sex and gender effects in stimulant treatment.

Method

We investigate the stimulant treatment trajectories of girls and women with ADHD from diagnosis and prescription to daily use and outcomes. We examine the impact of reproductive life transitions and hormonal fluctuations and their interactions with gender socialization and gendered expectations on treatment effectiveness, stigma, and adherence.

Results

By synthesizing existing literature, proposing testable predictions, and suggesting future research directions, we highlight the urgent need for studies that systematically investigate these factors.

Conclusion

Addressing these gaps could significantly improve treatment outcomes for girls and women with ADHD, particularly during biological and gender role transitions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Attention Deficit Disorder with HyperactivityCentral Nervous System StimulantsHumansFemaleMaleSex Factors

Stichwörter der Autor:innen

ADHDgender socializationmenstrual cyclemethylphenidatereproductive life transitionsstimulant treatment

Substanzen

Central Nervous System Stimulants

Autor:innen und Institutionen

  • University of Amsterdam, The Netherlands.
  • University of Groningen, The Netherlands.
  • Accare Child Study Center, Groningen, The Netherlands.

ORCID-Profile: Iris L Rapoport, Annabeth P Groenman

Förderung

  • universiteit van amsterdam

Zitieren

APA

Rapoport, I. L., & Groenman, A. P. (2025). A Review of Sex and Gender Factors in Stimulant Treatment for ADHD: Knowledge Gaps and Future Directions. Journal of Attention Disorders, 29(8), 602-616. https://doi.org/10.1177/10870547251315601

Vancouver

Rapoport IL, Groenman AP. A Review of Sex and Gender Factors in Stimulant Treatment for ADHD: Knowledge Gaps and Future Directions. Journal of Attention Disorders. 2025;29(8):602-616. doi:10.1177/10870547251315601

BibTeX
@article{Rapoport2025,
  author = {Rapoport, Iris L and Groenman, Annabeth P},
  title = {A Review of Sex and Gender Factors in Stimulant Treatment for ADHD: Knowledge Gaps and Future Directions},
  journal = {Journal of Attention Disorders},
  year = {2025},
  volume = {29},
  number = {8},
  pages = {602--616},
  doi = {10.1177/10870547251315601}
}
Kostenlos starten →